RUS

AVVA Pharmaceuticals Ltd , a research-based pharmaceutical company, announces the successful participation at the 2017 Vitafoods Europe exhibition in Geneva, Switzerland.

AVVA Pharmaceuticals Ltd , a research-based pharmaceutical company, announces the successful participation at the 2017 Vitafoods Europe exhibition in Geneva, Switzerland.

AVVA Pharmaceuticals Ltd , a research-based pharmaceutical company, announces the successful participation at the 2017 Vitafoods Europe exhibition in Geneva, Switzerland.

The expressed interest of the industry in our unique nutraceuticals, more than is perceived as a confirmation of the value proposition that accompanies our product lines.

Addressing common medical concerns through research based natural solutions/ nutraceuticals, products that enhance management approaches to broad and niche conditions, has met an enthusiastic audience of more than 140 industry professionals from 100+ different companies around the world, ranging from regional distributors, mid size nutraceutical/ pharmaceutical manufacturers, and the big pharma.

AVVA Pharmaceuticals Ltd conveys its deepest appreciation to all participants that devoted their time to visit our stand during the exhibition.

 About AVVA Pharmaceuticals:

AVVA Pharmaceuticals Ltd , a research-based pharmaceutical company, an industry leader in the development and production of innovative medicines that address common medical needs, building on its knowledge derived from the research of the human microbiome.

Our portfolio includes a number of inventions that will replace current standards in the field of infectious and metabolic diseases.

AVVA Pharmaceuticals also offers Clinical Genetics/ Metagenomics services through its state of art laboratory, launched in 2015, employing the latest technologies available in both equipment and methods.

Date: 15.06.2017